Skip to main content
    • Aa
    • Aa

Homocysteine levels and dementia risk in Yoruba and African Americans

  • Hugh C. Hendrie (a1) (a2) (a3), Olusegun Baiyewu (a4), Kathleen A. Lane (a5), Christianna Purnell (a2), Sujuan Gao (a5), Ann Hake (a6), Adesola Ogunniyi (a7), Oye Gureje (a4), Frederick W. Unverzagt (a3), Jill Murrell (a8), Mark A. Deeg (a9) and Kathleen Hall (a3)...

High levels of homocysteine have been associated with increased risk for dementia although results have been inconsistent. There are no reported studies from the developing world including Africa.


In this longitudinal study of two community-dwelling cohorts of elderly Yoruba and African Americans, levels of homocysteine, vitamin B12 and folate were measured from blood samples taken in 2001. These levels were compared in two groups, participants who developed incident dementia in the follow-up until 2009 (59 Yoruba and 101 African Americans) and participants who were diagnosed as cognitively normal or in the good performance category at their last follow-up (760 Yoruba and 811 African Americans). Homocysteine levels were divided into quartiles for each site.


After adjusting for age, education, possession of ApoE, smoking, and time of enrollment the higher quartiles of homocysteine were associated with a non-significant increase in dementia risk in the Yoruba (homocysteine quartile 4 vs. 1 OR: 2.19, 95% CI 0.95–5.07, p = 0.066). For the African Americans, there was a similar but non-significant relationship between higher homocysteine levels and dementia risk. There were no significant relationships between levels of vitamin B12 and folate and incident dementia in either site although folate levels were lower and vitamin B12 levers were higher in the Yoruba than in the African Americans.


Increased homocysteine levels were associated with a similar but non-significant increase in dementia risk for both Yoruba and African Americans despite significant differences in folate levels between the two sites.

Corresponding author
Correspondence should be addressed to: Hugh C. Hendrie, MB, ChB, DSc, Indiana University Center for Aging Research, 410 W 10th St., Suite 2000 Indianapolis, IN 46202, USA. Phone: +(317)-423-5591; Fax: +(317)-423-5695. Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

O. Baiyewu et al. (2002). Cognitive impairment in community-dwelling older Nigerians: clinical correlates and stability of diagnosis. European Journal of Neurology, 9, 573580.

D. E. Barnes and K. Yaffe (2011). The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurology, 10, 819828.

C. P. Ferri et al. (2005). Global prevalence of dementia: a Delphi consensus study. Lancet, 366, 21122117.

D. G. Hackam and S. S. Anand (2003). Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA, 290, 932940.

K. S. Hall , S. Gao , C. L. Emsley , A. O. Ogunniyi , O. Morgan and H. C. Hendrie (2000). Community screening interview for dementia (CSI ‘D’); performance in five disparate study sites. International Journal of Geriatric Psychiatry, 15, 521531.

H. C. Hendrie et al. (1988). The CAMDEX: a standardized instrument for the diagnosis of mental disorder in the elderly: a replication with a US sample. Journal of the American Geriatrics Society, 36, 402408.

H. C. Hendrie et al. (2001). Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA, 285, 739747.

R. C. Ho et al. (2011). Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and meta-regression. The American Journal of Geriatric Psychiatry, 19, 607617.

J. M. Kim et al. (2008). Changes in folate, vitamin B12 and homocysteine associated with incident dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 79, 864868.

M. Kivipelto et al. (2009). Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study. European Journal of Neurology, 16, 808813.

J. A. Luchsinger , M. X. Tang , S. Shea , J. Miller , R. Green and R. Mayeux (2004). Plasma homocysteine levels and risk of Alzheimer disease. Neurology, 62, 19721976.

G. McKhann , D. Drachman , M. Folstein , R. Katzman , D. Price and E. M. Stadlan (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939944.

Y. Ozarda , D. K. Sucu , B. Hizli and D. Aslan (2009). Rate of T alleles and TT genotype at MTHFR 677C->T locus or C alleles and CC genotype at MTHFR 1298A->C locus among healthy subjects in Turkey: impact on homocysteine and folic acid status and reference intervals. Cell Biochemistry and Function, 27, 568577.

B. L. Plassman , J. W. Williams Jr., J. R. Burke , T. Holsinger and S. Benjamin (2010). Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Annals of Internal Medicine, 153, 182193.

G. Ravaglia et al. (2008). Mild cognitive impairment: epidemiology and dementia risk in an elderly Italian population. Journal of the American Geriatrics Society, 56, 5158.

S. Seshadri et al. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. The New England Journal of Medicine, 346, 476483.

F. W. Unverzagt et al. (2001). Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology, 57, 16551662.

F. W. Unverzagt et al. (2011). Incidence and risk factors for cognitive impairment no dementia and mild cognitive impairment in African Americans. Alzheimer Disease and Associated Disorders, 25, 410.

D. S. Wald , A. Kasturiratne and M. Simmonds (2011). Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants. Alzheimers & Dementia, 7, 412417.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 1
Total number of PDF views: 14 *
Loading metrics...

Abstract views

Total abstract views: 205 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd September 2017. This data will be updated every 24 hours.